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Abstract
Bone defects associated with open fractures require a careful approach
and planning.  At initial presentation, an emergent irrigation and 
debridement is required.  Immediate definitive fixation is frequently 
safe, with the exception of those injuries that normally require staged 
management or very severe type IIIB and IIIC injuries.  Traumatic 
wounds that can be approximated primarily should be closed at the 
time of initial presentation.  Wounds that cannot be closed should have
a negative pressure wound therapy dressing applied. The need for 
subsequent debridements remains a clinical judgement, but all non-
viable tissue should be removed prior to definitive coverage.  Cefazolin
remains the standard of care for all open fractures, and type III injuries 
also require gram-negative coverage. Both the induced membrane 
technique (IMT) with staged bone grafting and distraction ostogenesis 
(DO) are excellent options for bony reconstruction.  Soft tissue 
coverage within one week of injury appears critical.
Introduction:
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Large bone defects caused by traumatic open fractures are complex 
and can overwhelm both the patient and the surgeon who together 
must make a large series of decisions on a lengthy reconstructive 
pathway.  The purpose of this article is to review the sequence of 
decision-making for these difficult injuries. Specifically, this article will 
address: 1) Initial debridement; 2) Subsequent debridements and 
medical management; and 3) Definitive reconstruction.  
Key Words: Bone defect, soft tissue management, trauma
Initial Debridement:
Management of the bony injury:  
How much to debride? 
Although open fractures are common and frequently studied, it 
remains true that surgical principles, rather than evidence based 
medicine, continues to guide open fracture debridement. Even 
contemporary investigations simply state that open fractures should be
debrided until “stable” and “all necrotic tissue and organic and 
inorganic contaminants have been removed”.1  Unfortunately 
quantifying debridement beyond these subjective descriptions remains
illusive.
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A frequent, specific scenario relevant to the topic of critical-sized bone 
defects is the large bone fragment that remains in the wound and is 
devoid of soft tissue attachments.  While retaining this fragment may 
risk infection and has led authors to recommend radical debridement,2 
removing such a fragment undoubtedly worsens the reconstructive 
challenge.   The decision of whether to retain or remove a major bony 
fragment requires weighing the risks and benefits.
The surgeon must first determine the value of the specific bone 
fragment.  On one end of the spectrum, there is the low value 
fragment, such as a moderate sized diaphyseal fragment, which can be
managed easily with contemporary techniques.  At the other extreme 
is the high value fragment, such as a large osteochondral fragment or 
whole extruded bone that is essentially irreplaceable.
When considering the low value diaphyseal fragment, the current 
practice is to remove this fragment.3  While direct comparisons of 
retention versus debridement of such fragments is lacking, it is 
generally accepted that devascularized fragments can serve as a nidus
for infection.  Although removal of such fragments often requires later 
procedures to achieve union, excision appears to be a justifiable step, 
as the treatment of a critical-sized defect is preferable to the 
management of established osteomyelitis.
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The same cannot be said for large osteochondral fragments.  Large 
sections of articular surface, once removed, allow for limited 
reconstructive options: allograft replacement, primary arthroplasty, or 
joint fusion.  In such a scenario, cleaning and retaining such a fragment
becomes a reasonable option.   An extruded talus represents a 
dramatic example of such a fragment. Short of re-implantation, there is
nothing a surgeon can do to re-establish normal anatomic relationships
from this injury, and multiple authors have reported limited success 
with debridement and retention.4-14  Other authors also have reported 
on the successful treatment of open fractures with cleansing and 
replantation of devitalized bone fragments.15-17  Thus, for high value, 
irreplaceable fragments, debridement and re-implantation remains a 
reasonable option.
External fixation or early definitive fixation?
Once the debridement is complete, the bone injury requires some form
of stabilization.  Outside of the need for damage control orthopedics 
and certain periarticular fractures, surgeons must decide between 
immediate definitive fixation and initial external fixation with later 
staged reconstruction.  Immediate definitive fixation is attractive as it 
eliminates the need for subsequent staged internal fixation.  The 
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primary argument for external fixation is it avoids the placement of 
definitive implants in a potentially contaminated wound beds.  
Brumback et al. evaluated the treatment of open femur fractures using
immediate definitive hardware placement, specifically an 
intramedullary nail.18  In this series, none of the 62 type I, II, or IIIA 
injuries were complicated by infection.  Results did worsen for IIIB 
injuries, where 3 of 27 patients developed an infection. 
Tornetta et al. compared immediate intramedullary nailing to definitive
external fixation for 29 type IIIB tibia fractures.19  All patients went on 
to union and one in each group experienced a deep infection.  
Similarly, Henley et al. evaluated the treatment of 174 type II, IIIA, and 
IIIB open tibia fractures treated with immediate intramedullary nail or 
definitive external fixation.20  While more severe injuries predicted 
higher infection and nonunion rates, the choice of an immediate 
intramedullary nail did not appear to significantly increase infection 
rates.  Both reports noted the relative ease of caring for patients with 
internal fixation versus external fixation.  While neither report directly 
compared immediate definitive fixation to external fixation and staged 
definitive fixation, higher rates of infection were not seen with initial 
definitive fixation in these series, suggesting that immediate internal 
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fixation following a thorough irrigation and debridement may be 
reasonable.
In summary, immediate definitive fixation, particularly with an 
intramedullary device, appears safe and justified in lower grade 
injuries (types I, II, and IIIA).  Infection rates are higher for type IIIB and
IIIC injuries and clinical judgment is still necessary in the selection 
between immediate internal fixation and staged fixation following 
initial external fixation.3
Management of the soft tissue injury:  
Should the wound be closed? 
Classic surgical principles dictate that infected and traumatic wounds 
be left open to avoid the containment of sepsis, and indeed open 
fracture wounds were often left open even if closeable in past 
decades.21-24  More recent evidence, however, appears to firmly 
suggest the benefit of immediate closure for type I, II, and IIIA open 
fractures.  Jenkinson et al., examining 146 patients with open lower 
extremity fractures, reported an infection rate of 4.1% in wounds that 
were primarily closed versus 17.8% that underwent delayed closure.25  
What to apply to a wound that cannot be closed?
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When the presenting wounds and their surgical extensions cannot be 
closed during the initial procedure, the surgeon must then decide how 
to cover the wound. Most of the early studies of open fractures 
suggested that such wounds be left completely or partially open after 
the initial debridement.21-24  Subsequent studies, however, suggested 
that allowing nosocomial infections into open wounds, rather than 
containing initial inoculums from the time of injury, may be the greater
concern.  In a study that examined 21 type IIIB open fractures that 
became infected, 57% of local sepsis was caused by organisms not 
present in the wounds during the first two weeks of treatment.26  
Traditional “wet-to-dry” dressings have given way to negative pressure
wound therapy (NPWT).  Multiple authors have now shown a dramatic 
reduction in infection rates with the use of NPWT (5-8%) compared 
with gauze dressings (~28%).27, 28  Similarly, other authors have shown 
both a reduction in gram-negative infection rates29 and polymicrobial 
infections with NPWT30.  
Subsequent debridements and medical management:
Are more debridements necessary? When is the wound clean?
Despite major advances in the care of severe lower extremity trauma 
in the last several decades, there is surprisingly little more than clinical
judgment to help surgeons decide when a wound is “clean”.  Although 
open wound cultures initially were felt to be useful as a guide for 
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further debridements and appropriate antibiotic selection, these 
cultures have not been shown to successfully predict later infection or 
an infecting organism.31-33  An on-going multi-center study (Bioburden) 
by the Major Extremity Trauma Research Consortium (METRC) is 
evaluating the utility of using polymerase chain reaction (PCR) 
techniques to characterize wound contamination/colonization at the 
time of wound closure in severe lower extremity injury.1  This 
investigation may provide some much needed insight into objectively 
determining the health of traumatic wounds.  Pending these results 
and further investigation, existing surgical principles still dictate 
management: All wounds should be debrided to stable, clean 
appearing margins, which may require multiple returns to the 
operating room depending on the visual evolution of the wound over 
time.
How are antibiotics managed from initial presentation to definitive 
fixation?
Prompt administration of antibiotics in open fracture management has 
been shown to have clear benefit.  Early publications from Patzakis, 
Gustillo, and Anderson clearly demonstrated the dramatic reduction in 
infection rates with the use of antibiotics and the necessity for gram-
negative coverage in type III open fractures.23, 34, 35  Since that time, 
investigators have emphasized the importance of administering 
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antibiotics early after injury. Infection rates have been shown to rise 
from 7% to 28% in those patients who received antibiotics within 60 
minutes compared to those who received antibiotics 90 minutes or 
later following injury.36
The specifics of which antibiotics to use is less clear.  Traditionally, a 
first generation cephalosporin has been recommended for type I and II 
open fractures and gentamicin has been added to type III injuries.23, 35  
With the aim of avoiding some of the complications of aminoglycocides
, more recent studies have explored the use of alternative gram-
negative coverage.  Ceftriaxone37, piperacillin/tazobactam38, 
cefotaxime39, and cefepime40 have all been investigated and been 
found to be either superior or no less effective.  The addition of 
penicillin for fecal or potential clostridial contamination is also 
recommended.41
A final consideration is the duration of antibiotics and their relationship
to closure or coverage of any open wounds.  Current Eastern 
Association for the Surgery of Trauma (EAST) Guidelines (Luchette, 
Hoff) recommend the administration of antibiotics for 24 hours after 
the treatment of type I and II fractures42, 43  This suggestion is 
supported by work that demonstrates no difference in infection rates 
between 1 and 5 days of antibiotic coverage.44  For type III open 
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injuries, EAST recommends extending coverage for up to 72 hours or 
24 hours after definitive closure or coverage.42, 43
Definitive Reconstruction:
Management of the bone injury:  
Induced membranes technique versus bone transport?
The primary contemporary means of reconstructing critical bone 
defects are the induced membranes technique, pioneered by 
Masquelet, and distraction osteogenesis, introduced by Ilizarov.  IMT 
places a cement spacer in a defect, allows the formation of a 
membrane around it over the course of 6 weeks, and then requires a 
secondary surgery to remove the spacer and place autograft into the 
membrane-surrounded defect.  DO generates new bone away from a 
defect at the site of a remote corticotomy; the bone fragment between
the corticotomy and the original critical defect is moved slowly to 
simultaneously narrow the critical defect and generate new bone in the
growing corticotomy site.  
The results of both IMT and DO are well summarized in recent meta-
analyses.  Morelli at al. analyzed 17 studies (427 patients) looking at 
the results of IMT.45  The mean size of the defects in this review was 
5.5cm, with 21% being > 10cm.  Complication rates were near 50%, 
with new infection (~10%), persistent infection or non-union (18%), 
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and the need for further surgery (~36%) all being common.  Despite 
this, the ultimate union rate at 15 months reached almost 90%.
Papakostidis similarly analyzed the results of DO, citing 37 manuscripts
(898 patients) with patients with a mean defect between 3.5-11.1cm.46 
Complications were again common with infection ranging from 0-60% 
for tibias and 0-6.2% for femurs, and re-fracture ranging from 0-19% in
tibias and 3.3-7.7% in femurs.  However, like IMT, eventual union rates 
were high, with rates of 94% in tibias and 96% in femurs.
No direct comparisons of IMT and DO exist to suggest which is 
preferable in a particular patient.  Given the heterogeneity of patients 
and these injuries, it is unlikely that one approach is truly superior to 
the other. Relatively small defects, defects that are not circumferential,
and defects that exist in the presence of stable internal fixation may 
be better managed with IMT.  In contrast, a large bone defect also 
associated with existing or prior infection or soft tissue loss might be 
better managed with DO.  The need for exceptional patient compliance
with fixator lengthening and hygiene, however, may make DO a less 
attractive option in some patients.
Management of the soft tissue injury:  
Timing of soft tissue coverage?
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Multiple prior authors have attempted to determine if a correlation 
exists between the timing of definitive flap coverage and patient 
outcomes.  The Lower Extremity Assessment Project (LEAP) group, in 
two separate publications, failed to demonstrate timing of flap 
coverage as an influence on complications rates.47,48  These authors 
used 72 hours as the distinction between early and late coverage.  
Later authors, using a single institution database and 7 days as the 
inflection point, were able to demonstrate the influence of timing on 
the rates of flap complications.49  While no difference in complication 
rates was noted for days 1-7, each day after 7 days resulted in an 11% 
increase rate of complications, and 16% increased risk of infection 
specifically.  As such, current evidence appears to suggest an 
aggressive approach for coverage of 3B open wounds.
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